Regional Release and Clearance of C-Type Natriuretic Peptides in the Human Circulation and Relation to Cardiac Function

Regional Release and Clearance of C-Type Natriuretic Peptides in the Human Circulation and Relation to Cardiac Function
复制标题

DOI:
10.1161/hypertensionaha.109.135608
复制
发表时间:
2009-09-01
期刊:
影响因子:
8.3
通讯作者:
Richards, A. Mark
Richards, A. Mark
中科院分区:
医学1区
文献类型:
--
作者:
Palmer, Suetonia C.;Prickett, Timothy C. R.;Richards, A. Mark

文献摘要

被引文献

相似文献

血浆c型利钠肽(CNP)的产生和清除以及氨基末端(NT)-proCNP的免疫反应性在人体循环中的特征仍然很差。因此,我们测量了120名心血管疾病研究对象(年龄:64.2 +/- 9.0岁;73%为男性)心导管插入期间多个组织床上CNP和NT-proCNP的动脉和静脉浓度。心脏、头颈部和肌肉骨骼组织对血浆CNP和NT-proCNP的贡献最明显(P < 0.05)。肝组织中NT-proCNP也有净释放(P < 0.001)。在肾、肝和肺组织中观察到CNP的阴性动静脉梯度(P < 0.05),表明净清除,而未发现NT-proCNP清除的组织特异性位点。在多变量分析中,年龄、平均肺动脉压、左室舒张末压、心肌危险的Brandt评分和肌钙蛋白I是循环CNP水平的独立预测因子。性别和肾功能是动脉NT-proCNP的独立预测因素。CNP在整个心脏的比例上升(+60%)小于脑利钠肽(+123%),但大于nt -原脑利钠肽(NT-proBNP)(+36%)和NT-proCNP(+42%,所有P < 0.001)。我们得出结论,心脏和头颈部组织是CNP的重要来源。循环CNP浓度与心脏血流动力学负荷和缺血负荷相关,而与NT-proCNP浓度无关。虽然心脏释放是最明显的,但许多其他组织释放NT-proCNP的免疫反应性,没有证据表明NT-proCNP降解的器官特异性位点。综上所述,与NT-proCNP相比,CNP在跨器官梯度的大小和方向上的差异表明,净全面性共分泌具有不同的清除机制。(高血压。2009;54:612 - 618)。
Production and clearance of plasma C-type natriuretic peptide (CNP) and amino terminal (NT)-proCNP immunoreactivity in the human circulation remain poorly characterized. Accordingly, we have measured arterial and venous concentrations of CNP and NT-proCNP across multiple tissue beds during cardiac catheterization in 120 subjects (age: 64.2 +/- 9.0 years; 73% men) investigated for cardiovascular disorders. The heart, head and neck, and musculoskeletal tissues made the clearest contributions to both plasma CNP and NT-proCNP (P < 0.05). Net release of NT-proCNP was also observed from hepatic tissue (P < 0.001). Negative arteriovenous gradients for CNP were observed across renal, hepatic, and pulmonary tissue (P < 0.05), indicating net clearance, whereas no tissue-specific site of NT-proCNP clearance was identified. Age, mean pulmonary artery pressure, left ventricular end diastolic pressure, Brandt score of myocardial jeopardy, and troponin I were independent predictors of circulating CNP levels in multivariable analysis. Sex and kidney function were independently predictive of arterial NT-proCNP. The proportional step-up of CNP (+60%) across the heart was less than for brain natriuretic peptide (+123%) but greater than for NT-pro-brain natriuretic peptide (NT-proBNP) (+36%) and NT-proCNP (+42%; P < 0.001 for all). We conclude that cardiac and head and neck tissue are important sources of CNP. Circulating CNP but not NT-proCNP concentrations are related to cardiac hemodynamic load and ischemic burden. Although cardiac release is most evident, multiple additional tissues release NT-proCNP immunoreactivity without evidence for an organ-specific site for NT-proCNP degradation. Taken together, differences in magnitude and direction of transorgan gradients for CNP compared with NT-proCNP suggest net generalized cosecretion with differing mechanisms of clearance. (Hypertension. 2009;54:612-618.)